{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:59:19Z","timestamp":1788919159705,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771178"],"award-info":[{"award-number":["31771178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600753"],"award-info":[{"award-number":["81600753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630040"],"award-info":[{"award-number":["81630040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82150710558"],"award-info":[{"award-number":["82150710558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151308"],"award-info":[{"award-number":["82151308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["ZX-2021ZD0203404-XZ"],"award-info":[{"award-number":["ZX-2021ZD0203404-XZ"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ajpath.2022.07.014","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:35:37Z","timestamp":1661340937000},"page":"1633-1646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Disruption of CD73-Derived and Equilibrative Nucleoside Transporter 1\u2013Mediated Adenosine Signaling Exacerbates Oxygen-Induced Retinopathy"],"prefix":"10.1016","volume":"192","author":[{"given":"Shuya","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2022.07.014_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retinal Eye Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ophtha.2017.11.009","article-title":"Glaucoma after lens-sparing vitrectomy for advanced retinopathy of prematurity","volume":"125","author":"Nudleman","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2022.07.014_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bjophthalmol-2017-310709","article-title":"A worldwide survey of retinopathy of prematurity screening","volume":"102","author":"Mora","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12886-018-0975-z","article-title":"Demographic profile and ocular characteristics of stage 5 retinopathy of prematurity at a referral center in Northwest China: implications for implementation","volume":"18","author":"Dou","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib5","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstrom","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2022.07.014_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-vision-091517-034018","article-title":"Retinal vasculature in development and diseases","volume":"4","author":"Sun","year":"2018","journal-title":"Annu Rev Vis Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ophtha.2018.12.012","article-title":"Laser treatment for retinopathy of prematurity: a decade since ETROP","volume":"126","author":"Emami","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2022.07.014_bib8","doi-asserted-by":"crossref","first-page":"101097","DOI":"10.1016\/j.ajoc.2021.101097","article-title":"Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity","volume":"22","author":"Jeon","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajpath.2022.07.014_bib9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.ophtha.2018.08.018","article-title":"Exploring the limits: the challenge of finding the right dose for anti-vascular endothelial growth factor treatment in retinopathy of prematurity","volume":"125","author":"Stahl","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2022.07.014_bib10","doi-asserted-by":"crossref","first-page":"F170","DOI":"10.1136\/archdischild-2011-301148","article-title":"Are we there yet? bevacizumab therapy for retinopathy of prematurity","volume":"98","author":"Darlow","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajpath.2022.07.014_bib11","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1755-3768.2012.02469.x","article-title":"Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity","volume":"91","author":"Hoerster","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib12","doi-asserted-by":"crossref","first-page":"107513","DOI":"10.1016\/j.pharmthera.2020.107513","article-title":"Keep an eye on adenosine: its role in retinal inflammation","volume":"210","author":"Santiago","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2022.07.014_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(25)06782-1","article-title":"Nomenclature and classification of purinoceptors","volume":"46","author":"Fredholm","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ajpath.2022.07.014_bib14","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1152\/ajpregu.00840.2004","article-title":"Growth regulation of the vascular system: an emerging role for adenosine","volume":"289","author":"Adair","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib15","first-page":"273","article-title":"Adenosine formation: evidence for a direct biochemical link with energy metabolism","volume":"6","author":"Newby","year":"1985","journal-title":"Adv Myocardiol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"1808","author":"Gomes","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2022.07.014_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(92)90066-I","article-title":"Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia","volume":"579","author":"Matsumoto","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0197-0186(95)00154-9","article-title":"Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex","volume":"29","author":"Phillis","year":"1996","journal-title":"Neurochem Int"},{"key":"10.1016\/j.ajpath.2022.07.014_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1471-4159.2000.0750795.x","article-title":"Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia","volume":"75","author":"Parkinson","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2022.07.014_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib21","doi-asserted-by":"crossref","first-page":"702581","DOI":"10.3389\/fnins.2021.702581","article-title":"Adenosine A2A receptors as biomarkers of brain diseases","volume":"15","author":"Moreira-de-Sa","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.RES.81.2.154","article-title":"Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release","volume":"81","author":"Decking","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib23","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1182\/blood-2007-11-126763","article-title":"HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak","volume":"111","author":"Morote-Garcia","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2022.07.014_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2016.03.007","article-title":"Why do premature newborn infants display elevated blood adenosine levels?","volume":"90","author":"Panfoli","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ajpath.2022.07.014_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1350-9462(02)00058-7","article-title":"Retinal vascular development and oxygen-induced retinopathy: a role for adenosine","volume":"22","author":"Lutty","year":"2003","journal-title":"Prog Retinal Eye Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41467-017-00551-2","article-title":"Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2022.07.014_bib27","first-page":"346","article-title":"Adenosine and brain ischemia","volume":"4","author":"Rudolphi","year":"1992","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1016\/j.ajpath.2022.07.014_bib28","first-page":"23","article-title":"Adenosine--an endogenous neuroprotective metabolite and neuromodulator","volume":"43","author":"Deckert","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.ajpath.2022.07.014_bib29","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2174\/138161208784480126","article-title":"Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors","volume":"14","author":"Chen","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajpath.2022.07.014_bib30","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1167\/iovs.09-4900","article-title":"Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina","volume":"51","author":"Liu","year":"2010","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib31","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.2174\/092986711797535335","article-title":"Adenosine A(1) receptors in the central nervous system: their functions in health and disease, and possible elucidation by PET imaging","volume":"18","author":"Paul","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ajpath.2022.07.014_bib32","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1167\/iovs.15-17202","article-title":"Adenosine A1 receptors selectively modulate oxygen-induced retinopathy at the hyperoxic and hypoxic phases by distinct cellular mechanisms","volume":"56","author":"Zhang","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/bs.vh.2014.12.014","article-title":"Adenosine transporters and receptors: key elements for retinal function and neuroprotection","volume":"98","author":"Alexandre dos Santos-Rodrigues","year":"2015","journal-title":"Vitam Horm"},{"key":"10.1016\/j.ajpath.2022.07.014_bib34","doi-asserted-by":"crossref","first-page":"e21842","DOI":"10.1096\/fj.202100414RR","article-title":"Adenosine A2A receptor antagonism protects against hyperoxia-induced retinal vascular loss via cellular proliferation","volume":"35","author":"Zhong","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2022.07.014_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s10020-018-0038-1","article-title":"Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy","volume":"24","author":"Zhou","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib36","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1096\/fj.201601285R","article-title":"Caffeine preferentially protects against oxygen-induced retinopathy","volume":"31","author":"Zhang","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2022.07.014_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2016.105","article-title":"Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy","volume":"80","author":"Aranda","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib38","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000317057","article-title":"Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes","volume":"46","author":"Charles","year":"2011","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mam.2017.01.001","article-title":"Adenosine receptors and caffeine in retinopathy of prematurity","volume":"55","author":"Chen","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib41","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/156802611795347582","article-title":"Molecular biology of nucleoside transporters and their distributions and functions in the brain","volume":"11","author":"Parkinson","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.ajpath.2022.07.014_bib42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20040915","article-title":"Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia","volume":"200","author":"Thompson","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib43","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/glia.20900","article-title":"Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy","volume":"58","author":"Dorrell","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.ajpath.2022.07.014_bib45","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat Protocols"},{"key":"10.1016\/j.ajpath.2022.07.014_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","article-title":"Retinal vasculature development in health and disease","volume":"63","author":"Selvam","year":"2018","journal-title":"Prog Retinal Eye Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib47","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/ATVBAHA.113.301331","article-title":"Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A","volume":"33","author":"Rivera","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib48","first-page":"218","article-title":"5' Nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy","volume":"41","author":"Lutty","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib49","first-page":"230","article-title":"Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy","volume":"41","author":"Taomoto","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0074-7742(08)60723-0","article-title":"Adenosine and neuroprotection","volume":"40","author":"Fredholm","year":"1997","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0165-6147(92)90141-R","article-title":"Neuroprotective role of adenosine in cerebral ischaemia","volume":"13","author":"Rudolphi","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ajpath.2022.07.014_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.pharmtox.45.120403.095731","article-title":"Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs","volume":"45","author":"Fredholm","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1023\/A:1017971831046","article-title":"Role of adenosine receptors in neuroprotective effect during global cerebral ischemia","volume":"131","author":"Kulinsky","year":"2001","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbrc.2013.05.023","article-title":"Potential roles of adenosine deaminase-2 in diabetic retinopathy","volume":"436","author":"Elsherbiny","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2022.07.014_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.trsl.2015.11.005","article-title":"Selective A(2A) receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury","volume":"169","author":"Madeira","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib56","doi-asserted-by":"crossref","first-page":"e3065","DOI":"10.1038\/cddis.2017.451","article-title":"Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage","volume":"8","author":"Boia","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2022.07.014_bib57","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jnc.13724","article-title":"How does adenosine control neuronal dysfunction and neurodegeneration?","volume":"139","author":"Cunha","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2022.07.014_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signalling"},{"key":"10.1016\/j.ajpath.2022.07.014_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imr.12571","article-title":"Extracellular nucleosides and nucleotides as immunomodulators","volume":"280","author":"Kepp","year":"2017","journal-title":"Immunological Rev"},{"key":"10.1016\/j.ajpath.2022.07.014_bib60","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1471-4159.2003.02266.x","article-title":"Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons","volume":"88","author":"Parkinson","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2022.07.014_bib61","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/jnr.21789","article-title":"Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes","volume":"86","author":"Zamzow","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.15252\/emmm.201607066","article-title":"Intracellular adenosine regulates epigenetic programming in endothelial cells to promote angiogenesis","volume":"9","author":"Xu","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib63","doi-asserted-by":"crossref","first-page":"H2116","DOI":"10.1152\/ajpheart.2000.279.5.H2116","article-title":"Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts","volume":"279","author":"Gu","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"Young","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ajpath.2022.07.014_bib65","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/BST20160038","article-title":"The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey","volume":"44","author":"Young","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ajpath.2022.07.014_bib66","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.2040-4603.2018.tb00034.x","article-title":"Intestinal nucleoside transporters: function, expression, and regulation","volume":"8","author":"Pastor-Anglada","year":"2018","journal-title":"Compr Physiol"},{"key":"10.1016\/j.ajpath.2022.07.014_bib67","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/jnr.21718","article-title":"Astrocytes affect the profile of purines released from cultured cortical neurons","volume":"86","author":"Zamzow","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ajpath.2022.07.014_bib68","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0028-3908(02)00083-7","article-title":"Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions","volume":"43","author":"Parkinson","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajpath.2022.07.014_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1471-4159.2011.07242.x","article-title":"Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions","volume":"118","author":"Zhang","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2022.07.014_bib70","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","article-title":"Adenosine, an endogenous distress signal, modulates tissue damage and repair","volume":"14","author":"Fredholm","year":"2007","journal-title":"Cell Death Differ"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022002462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022002462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:08:43Z","timestamp":1762081723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944022002462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0002944022002462"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.07.014","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of CD73-Derived and Equilibrative Nucleoside Transporter 1\u2013Mediated Adenosine Signaling Exacerbates Oxygen-Induced Retinopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}